MAIA Biotechnology Inc. (MAIA)
AMEX: MAIA
· Real-Time Price · USD
1.44
-0.03 (-2.04%)
At close: Oct 15, 2025, 3:59 PM
1.44
0.00%
After-hours: Oct 15, 2025, 04:21 PM EDT
-2.04% (1D)
| Bid | 1.41 |
| Market Cap | 47.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -16.17M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -2.67 |
| Forward PE | -2.27 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.5 |
| Volume | 369,908 |
| Avg. Volume (20D) | 488,828 |
| Open | 1.48 |
| Previous Close | 1.47 |
| Day's Range | 1.41 - 1.52 |
| 52-Week Range | 1.40 - 3.48 |
| Beta | 0.03 |
| Ex-Dividend Date | n/a |
About MAIA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAIA
Website n/a
1 month ago
+7.14%
MAIA Biotechnology shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+9.24%
MAIA Biotechnology shares are trading higher after the company announced it dosed its first patient in its Taiwan expansion stage of the THIO-101 Phase 2 trial.
